HomeAC6 • FRA
add
AlzeCure Pharma AB
Previous close
€0.15
Day range
€0.14 - €0.15
Year range
€0.11 - €0.45
Market cap
167.89M SEK
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.00M | 2.42% |
Net income | -9.80M | -2.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.89M | -2.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.04M | -64.56% |
Total assets | 22.69M | -60.87% |
Total liabilities | 8.72M | 24.58% |
Total equity | 13.97M | — |
Shares outstanding | 62.09M | — |
Price to book | 0.66 | — |
Return on assets | -91.41% | — |
Return on capital | -132.44% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.80M | -2.71% |
Cash from operations | -10.06M | -135.82% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -10.06M | -135.76% |
Free cash flow | -6.51M | 40.38% |
About
Founded
2012
Website
Employees
11